Bodal Chemicals has officially announced their financial results for the fiscal year 2026, receiving a clean bill of health from auditors. Additionally, they've decided to sell off a non-essential facility located in Ahmedabad. The impact of this sale on overall operations is expected to be minimal.

Bodal Chemicals reports a significant 40% increase in Q4 EBITDA, reaching ₹697M compared to last year. The company's margins also improved, climbing up to 12.1%. This suggests better profitability for the quarter ending compared to the previous year.